LXU Fundamental Analysis - LSB INDUSTRIES INC

Fundamental Rating

Overall LXU gets a fundamental rating of 3 out of 10. We evaluated LXU against 85 industry peers in the Chemicals industry. While LXU seems to be doing ok healthwise, there are quite some concerns on its profitability. LXU is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year LXU was profitable.

LXU had a positive operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: LXU reported negative net income in multiple years.

LXU had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

LXU's Return On Assets of -2.26% is on the low side compared to the rest of the industry. LXU is outperformed by 68.24% of its industry peers.

LXU's Return On Equity of -5.43% is on the low side compared to the rest of the industry. LXU is outperformed by 67.06% of its industry peers.

		Industry Rank	Sector Rank
ROA	-2.26%
ROE	-5.43%
ROIC	N/A

ROA(3y)5.51%

ROA(5y)-2.47%

ROE(3y)15.37%

ROE(5y)-5.05%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of LXU has declined.

With a Gross Margin value of 7.56%, LXU is not doing good in the industry: 85.88% of the companies in the same industry are doing better.

In the last couple of years the Gross Margin of LXU has grown nicely.

The Profit Margin and Operating Margin are not available for LXU so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	7.56%

OM growth 3Y-59.74%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-28.46%

GM growth 5Y46.21%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

LXU does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for LXU has been reduced compared to 1 year ago.

LXU has more shares outstanding than it did 5 years ago.

The debt/assets ratio for LXU has been reduced compared to a year ago.

2.2 Solvency

LXU has an Altman-Z score of 1.36. This is a bad value and indicates that LXU is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of 1.36, LXU is not doing good in the industry: 68.24% of the companies in the same industry are doing better.

LXU has a Debt/Equity ratio of 0.99. This is a neutral value indicating LXU is somewhat dependend on debt financing.

LXU has a worse Debt to Equity ratio (0.99) than 67.06% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.99
Debt/FCF	N/A
Altman-Z	1.36

ROIC/WACCN/A

WACC8.95%

2.3 Liquidity

A Current Ratio of 2.51 indicates that LXU has no problem at all paying its short term obligations.

With a decent Current ratio value of 2.51, LXU is doing good in the industry, outperforming 70.59% of the companies in the same industry.

A Quick Ratio of 2.29 indicates that LXU has no problem at all paying its short term obligations.

LXU has a better Quick ratio (2.29) than 83.53% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.51
Quick Ratio	2.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

LXU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.67%, which is quite impressive.

Looking at the last year, LXU shows a decrease in Revenue. The Revenue has decreased by -4.23% in the last year.

LXU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.43% yearly.

EPS 1Y (TTM)56.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-69.23%

Revenue 1Y (TTM)-4.23%

Revenue growth 3Y-2.07%

Revenue growth 5Y7.43%

Sales Q2Q%3.78%

3.2 Future

LXU is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.90% yearly.

Based on estimates for the next years, LXU will show a small growth in Revenue. The Revenue will grow by 3.20% on average per year.

EPS Next Y-40.48%

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

EPS Next 5Y0.9%

Revenue Next Year10.02%

Revenue Next 2Y5.46%

Revenue Next 3Y5.98%

Revenue Next 5Y3.2%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.51, LXU is valued correctly.

Based on the Price/Earnings ratio, LXU is valued a bit cheaper than 61.18% of the companies in the same industry.

Compared to an average S&P500 Price/Earnings ratio of 26.91, LXU is valued a bit cheaper.

With a Price/Forward Earnings ratio of 73.17, LXU can be considered very expensive at the moment.

Compared to the rest of the industry, the Price/Forward Earnings ratio of LXU indicates a slightly more expensive valuation: LXU is more expensive than 71.76% of the companies listed in the same industry.

LXU is valuated expensively when we compare the Price/Forward Earnings ratio to 21.46, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	16.51
Fwd PE	73.17

4.2 Price Multiples

LXU's Enterprise Value to EBITDA ratio is in line with the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	9.73

4.3 Compensation for Growth

A cheap valuation may be justified as LXU's earnings are expected to decrease with -8.48% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

LXU does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LSB INDUSTRIES INC

NYSE:LXU (6/25/2025, 12:13:31 PM)

7.76

-0.01 (-0.13%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)04-29 2025-04-29/amc

Earnings (Next)07-29 2025-07-29/amc

Inst Owners54.39%

Inst Owner Change2.53%

Ins Owners4.22%

Ins Owner Change0.44%

Market Cap557.79M

Analysts77.78

Price Target8.39 (8.12%)

Short Float %4.3%

Short Ratio4.24

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)102.45%

Min EPS beat(2)69.76%

Max EPS beat(2)135.15%

EPS beat(4)4

Avg EPS beat(4)103.34%

Min EPS beat(4)69.76%

Max EPS beat(4)135.15%

EPS beat(8)6

Avg EPS beat(8)43.21%

EPS beat(12)8

Avg EPS beat(12)22.5%

EPS beat(16)10

Avg EPS beat(16)37.33%

Revenue beat(2)2

Avg Revenue beat(2)9.9%

Min Revenue beat(2)6.25%

Max Revenue beat(2)13.55%

Revenue beat(4)3

Avg Revenue beat(4)6.5%

Min Revenue beat(4)-6.62%

Max Revenue beat(4)13.55%

Revenue beat(8)7

Avg Revenue beat(8)5.28%

Revenue beat(12)10

Avg Revenue beat(12)4.96%

Revenue beat(16)11

Avg Revenue beat(16)3.09%

PT rev (1m)-4.14%

PT rev (3m)-18.16%

EPS NQ rev (1m)1.02%

EPS NQ rev (3m)43.48%

EPS NY rev (1m)37.5%

EPS NY rev (3m)-33.56%

Revenue NQ rev (1m)2.95%

Revenue NQ rev (3m)1.3%

Revenue NY rev (1m)-1.75%

Revenue NY rev (3m)2.53%

Valuation

		Industry Rank	Sector Rank
PE	16.51
Fwd PE	73.17
P/S	1.06
P/FCF	N/A
P/OCF	8.05
P/B	1.14
P/tB	1.14
EV/EBITDA	9.73

EPS(TTM)0.47

EY6.06%

EPS(NY)0.11

Fwd EY1.37%

FCF(TTM)-0.36

FCFYN/A

OCF(TTM)0.96

OCFY12.42%

SpS7.34

BVpS6.82

TBVpS6.81

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-2.26%
ROE	-5.43%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	7.56%
FCFM	N/A

ROA(3y)5.51%

ROA(5y)-2.47%

ROE(3y)15.37%

ROE(5y)-5.05%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)9.64%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y-59.74%

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-28.46%

GM growth 5Y46.21%

F-Score4

Asset Turnover0.45

Health

		Industry Rank	Sector Rank
Debt/Equity	0.99
Debt/FCF	N/A
Debt/EBITDA	6.46
Cap/Depr	122.77%
Cap/Sales	17.98%
Interest Coverage	N/A
Cash Conversion	92.06%
Profit Quality	N/A
Current Ratio	2.51
Quick Ratio	2.29
Altman-Z	1.36

F-Score4

WACC8.95%

ROIC/WACCN/A

Cap/Depr(3y)96.58%

Cap/Depr(5y)76.59%

Cap/Sales(3y)11.38%

Cap/Sales(5y)9.83%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)56.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-69.23%

EPS Next Y-40.48%

EPS Next 2Y-56.48%

EPS Next 3Y-8.48%

EPS Next 5Y0.9%

Revenue 1Y (TTM)-4.23%

Revenue growth 3Y-2.07%

Revenue growth 5Y7.43%

Sales Q2Q%3.78%

Revenue Next Year10.02%

Revenue Next 2Y5.46%

Revenue Next 3Y5.98%

Revenue Next 5Y3.2%

EBIT growth 1Y-106.18%

EBIT growth 3Y-60.57%

EBIT growth 5YN/A

EBIT Next Year2094.57%

EBIT Next 3Y191.05%

EBIT Next 5Y92.67%

FCF growth 1Y-109.71%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-78.3%

OCF growth 3Y-0.4%

OCF growth 5Y110.4%

LSB INDUSTRIES INC (LXU) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens